Literature DB >> 14494433

Relation of positive L.E.-cell preparations to activity of lupus erythematosus and corticosteroid therapy.

N F ROTHFIELD, N PACE.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/therapy; LUPUS ERYTHEMATOSUS/therapy

Mesh：

Substances：

Year:  1962        PMID： 14494433     DOI： 10.1056/NEJM196203152661103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  SLOWLY SEDIMENTING MERCAPTOETHANOL-RESISTANT ANTINUCLEAR FACTORS RELATED ANTIGENICALLY TO M IMMUNOGLOBULINS (GAMMA-1M-GLOBULIN) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  N F ROTHFIELD; B FRANGIONE; E C FRANKLIN
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

2.  CLINICAL SIGNIFICANCE OF THE L.E.-CELL PHENOMENON IN RHEUMATOID ARTHRITIS.

Authors:  L J GOLDFINE; M B STEVENS; A T MASI; L E SHULMAN
Journal:  Ann Rheum Dis       Date:  1965-03       Impact factor: 19.103

3.  [Studies of the efficacy of 3 different methods for the demonstration of antinuclear factors: the direct LE cell test, the loose body test and the antihuman globulin consumption test].

Authors:  A Beickert; E Bässler
Journal:  Klin Wochenschr       Date:  1965-06-15

4.  Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.

Authors:  M A Schrager; N F Rothfield
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

5.  Activation of the alternative complement pathway in systemic lupus erythematosus.

Authors:  M R Wilson; C M Arroyave; R M Nakamura; J H Vaughan; E M Tan
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

6.  Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseases.

Authors:  W J Morrow; D A Isenberg; H F Parry; L Shen; E E Okolie; F Farzaneh; S Shall; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis.

Authors:  T Nakamura; P G Board; K Matsushita; H Tanaka; T Matsuyama; T Matsuda
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

8.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

9.  Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes.

Authors:  R P Kimberly; T M Parris; R D Inman; J S McDougal
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 10.  Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer.

Authors:  A Mackiewicz; K Mackiewicz
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.